cinacalcet has been researched along with Vomiting in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Johnson, DW; Mavridis, D; Palmer, SC; Ruospo, M; Strippoli, GFM; Tonelli, M | 1 |
| Akizawa, T; Fukagawa, M; Haruyama, W; Hisada, Y; Kawata, T; Masuda, N; Miyazaki, H; Murai, M; Shoukei, Y; Tokunaga, S; Wada, M; Yanagida, T | 1 |
| Ariceta, G; Dehmel, B; Hidalgo, G; Iles, JN; Jiang, X; Laskin, B; Schaefer, F; Shahinfar, S; Vande Walle, J; Warady, BA | 1 |
| Covic, A; Craig, JC; Messa, P; Nistor, I; Palmer, SC; Pellegrini, F; Strippoli, GF; Tonelli, M | 1 |
| Block, GA; Bushinsky, DA; Cheng, S; Chertow, GM; Cunningham, J; Dehmel, B; Drueke, TB; Ketteler, M; Kewalramani, R; Martin, KJ; Moe, SM; Patel, UD; Silver, J; Sun, Y; Wang, H | 1 |
| Emery, M; Padhi, D; Salfi, M | 1 |
| Lopez, J; Norman, J; Politz, D | 1 |
2 review(s) available for cinacalcet and Vomiting
| Article | Year |
|---|---|
Comparative Effectiveness of Calcimimetic Agents for Secondary Hyperparathyroidism in Adults: A Systematic Review and Network Meta-analysis.
Topics: Adult; Calcimimetic Agents; Calcium; Cardiovascular Diseases; Cinacalcet; Comorbidity; Female; Fractures, Bone; Heart Failure; Humans; Hyperparathyroidism, Secondary; Male; Mortality; Naphthalenes; Nausea; Parathyroid Hormone; Peptides; Pyrrolidines; Randomized Controlled Trials as Topic; Renal Dialysis; Renal Insufficiency, Chronic; Treatment Outcome; Vomiting | 2020 |
Cinacalcet in patients with chronic kidney disease: a cumulative meta-analysis of randomized controlled trials.
Topics: Calcimimetic Agents; Calcium Metabolism Disorders; Cardiovascular Diseases; Cinacalcet; Humans; Hyperparathyroidism; Naphthalenes; Nausea; Parathyroid Hormone; Parathyroidectomy; Renal Insufficiency, Chronic; Vomiting | 2013 |
3 trial(s) available for cinacalcet and Vomiting
| Article | Year |
|---|---|
A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet in pediatric patients with chronic kidney disease and secondary hyperparathyroidism receiving dialysis.
Topics: Adolescent; Calcimimetic Agents; Calcium; Child; Cinacalcet; Double-Blind Method; Female; Humans; Hyperparathyroidism, Secondary; Hypertension; Hypocalcemia; Male; Nausea; Parathyroid Hormone; Placebos; Renal Dialysis; Renal Insufficiency, Chronic; Treatment Outcome; Vitamin D; Vomiting | 2019 |
Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: A Randomized Clinical Trial.
Topics: Administration, Oral; Biomarkers; Calcimimetic Agents; Calcium; Cinacalcet; Double-Blind Method; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperparathyroidism, Secondary; Infusions, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Nausea; Parathyroid Hormone; Peptides; Renal Dialysis; Time Factors; Vomiting | 2017 |
Cinacalcet does not affect the activity of cytochrome P450 3A enzymes, a metabolic pathway for common immunosuppressive agents : a randomized, open-label, crossover, single-centre study in healthy volunteers.
Topics: Administration, Oral; Adolescent; Adult; Area Under Curve; Calcium; Calcium Channel Agonists; Cinacalcet; Cross-Over Studies; Cytochrome P-450 CYP3A; Data Interpretation, Statistical; Female; Half-Life; Humans; Hypnotics and Sedatives; Immunosuppressive Agents; Male; Midazolam; Middle Aged; Naphthalenes; Nausea; Paresthesia; Vomiting; Young Adult | 2008 |
3 other study(ies) available for cinacalcet and Vomiting
| Article | Year |
|---|---|
A novel calcimimetic agent, evocalcet (MT-4580/KHK7580), suppresses the parathyroid cell function with little effect on the gastrointestinal tract or CYP isozymes in vivo and in vitro.
Topics: Administration, Oral; Animals; Calcimimetic Agents; Callithrix; Cinacalcet; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Gastrointestinal Tract; HEK293 Cells; Humans; Isoenzymes; Male; Molecular Structure; Parathyroid Glands; Parathyroid Hormone; Rats, Wistar; Receptors, Calcium-Sensing; Renal Insufficiency, Chronic; Vomiting | 2018 |
Cinacalcet (Sensipar) provides no measurable clinical benefits for patients with primary hyperparathyroidism and may accelerate bone loss with prolonged use.
Topics: Adult; Aged; Aged, 80 and over; Bone Density; Calcium; Cinacalcet; Female; Follow-Up Studies; Humans; Hyperparathyroidism, Primary; Male; Middle Aged; Naphthalenes; Nausea; Osteoporosis; Treatment Failure; Vomiting; Young Adult | 2012 |
Cinacalcet (sensipar).
Topics: Cinacalcet; Controlled Clinical Trials as Topic; Dose-Response Relationship, Drug; Fees, Pharmaceutical; Hypocalcemia; Naphthalenes; Nausea; Vomiting | 2004 |